Effect of overexpression of ERK1/2 and MDR1 on chemoresistance in advanced gastric cancer patients

被引：0
|
作者：
Ghosh, Sushmita [1 ]
Pal, Ranita [1 ]
Mistry, Tanuma [1 ]
Sahoo, Pranab Kumar [1 ]
Mahata, Sutapa [1 ]
Sarkar, Sinjini [1 ]
Choudhury, Trisha [1 ]
Banerjee, Raya [1 ]
Chakrabarti, Jayanta [1 ]
Mukherjee, Kalyan Kusum [1 ]
Alam, Neyaz [1 ]
Mandal, Syamsundar [1 ]
Nasare, Vilas [1 ]
机构：
[1] Chittaranjan Natl Canc Inst, Kolkata, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16051
引用
收藏
页数：1
相关论文
共 50 条
  • [41] MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
    Hoffmann, Andreas-Claudius
    Wild, Peter
    Leicht, Christina
    Bertz, Simone
    Danenberg, Kathleen D.
    Danenberg, Peter V.
    Stoehr, Robert
    Stoeckle, Michael
    Lehmann, Jan
    Schuler, Martin
    Hartmann, Arndt
    NEOPLASIA, 2010, 12 (08): : 628 - 636
  • [42] MDR1 polymorphisms are associated with sensitivity to platinum-based chemotherapy in gastric cancer
    Zhao, Jianqiang
    Ouyang, Aimei
    Su, Xinyou
    Dou, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2235 - 2240
  • [43] Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway
    Wang, Xiaofeng
    Yu, Zhenjia
    Zhou, Quan
    Wu, Xiongyan
    Chen, Xuehua
    Li, Jianfang
    Zhu, Zhenggang
    Liu, Bingya
    Su, Liping
    ONCOTARGET, 2016, 7 (06) : 7066 - 7079
  • [44] Effect of MDR1 gene promoter methylation in patients with ulcerative colitis
    Tahara, Tomomitsu
    Shibata, Tomoyuki
    Nakamura, Masakatsu
    Yamashita, Hiromi
    Yoshioka, Daisuke
    Okubo, Masaaki
    Maruyama, Naoko
    Kamano, Toshiaki
    Kamiya, Yoshio
    Nakagawa, Yoshihito
    Fujita, Hiroshi
    Nagasaka, Mitsuo
    Iwata, Masami
    Takahama, Kazuya
    Watanabe, Makoto
    Hirata, Ichiro
    Arisawa, Tomiyasu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (04) : 521 - 527
  • [45] Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population
    Sabahi, Z.
    Salek, R.
    Heravi, R. E.
    Mosaffa, F.
    Avanaki, Z. J.
    Behravan, J.
    INDIAN JOURNAL OF CANCER, 2010, 47 (03) : 317 - 321
  • [46] Tissue tranglutaminase-2 promotes gastric cancer progression via ERK1/2 pathway
    Su, Liping
    Wang, Xiaofeng
    Zhou, Quan
    Wu, Xiongyan
    Liu, Bingya
    CANCER RESEARCH, 2016, 76
  • [47] Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients
    Kim, Hak Jae
    Kim, Hyung-Ki
    Kwon, Jun-Tack
    Lee, Sun-hyo
    el Park, Sam
    Gil, Hyo-Wook
    Song, Ho-yeon
    Hong, Sae-yong
    SCIENTIFIC REPORTS, 2016, 6
  • [48] Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer
    Muriel Arnal
    Noreli Franco
    Pierre Fargeot
    Jean-Marc Riedinger
    Patrick Brunet-Lecomte
    Sarab Lizard-Nacol
    Breast Cancer Research and Treatment, 2000, 61 : 13 - 20
  • [49] EXPRESSION OF THE MDR1 GENE IN HUMAN GASTRIC AND COLORECTAL CARCINOMAS
    MIZOGUCHI, T
    YAMADA, K
    FURUKAWA, T
    HIDAKA, K
    HISATSUGU, T
    SHIMAZU, H
    TSURUO, T
    SUMIZAWA, T
    AKIYAMA, S
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (21) : 1679 - 1683
  • [50] Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma
    Salas, Sebastien
    Jiguet-Jiglaire, Carine
    Campion, Loic
    Bartoli, Catherine
    Frassineti, Frederic
    Deville, Jean-Laurent
    De Paula, Andre Maues
    Forest, Fabien
    Jezequel, Pascal
    Gentet, Jean-Claude
    Bouvier, Corinne
    BMC CANCER, 2014, 14
12345